The United States has lost its measles elimination status after 26 years, as the country faces its largest outbreak in more than three decades. The Pan American Health Organization (PAHO), the Americas branch of the World Health Organization (WHO), declared measles endemic in the US on Tuesday, finding that the same strain had circulated continuously for at least 12 months.

Measles was declared eliminated in the US in 2000. PAHO’s decision followed a review of epidemiological and laboratory evidence submitted by the US Centers for Disease Control and Prevention (CDC). CDC figures show approximately 7,700 measles infections in the country since the beginning of 2025.

The CDC has confirmed six measles-related deaths this year. State health officials in Pennsylvania, Wisconsin and New York have reported 10 deaths combined, a discrepancy that has fuelled tensions between federal and state health authorities over how measles fatalities are classified and counted.

Vaccine hesitancy has grown under Health Secretary Robert F Kennedy Jr, who has repeatedly cast doubt on vaccine safety despite scientific evidence to the contrary. Before taking office, Kennedy claimed that no vaccine was “safe and effective” and promoted the discredited theory that vaccines cause autism. As health secretary under US President Donald Trump, he has questioned the MMR vaccine’s ability to protect children and suggested its effectiveness wanes by about 4.5 percent a year. He has also said it contains “aborted fetus debris”, a claim experts have rejected as false.

Children are commonly given the measles vaccine in a combined shot with mumps and rubella vaccines, known as MMR. The vaccination rate among US preschoolers has fallen to about 92 percent, below the level experts say is needed to prevent major outbreaks.

Matt Ferrari, a biology professor and director of Pennsylvania State University’s Center for Infectious Disease Dynamics, said the loss of elimination status could serve as a wake-up call for public health officials. “This should be a humbling statement for the United States,” Ferrari told Al Jazeera.

The US had been seen as a model for measles control, Ferrari said. “It was a motivating achievement that we use to drive support for measles elimination programmes all around the world,” he said. “Now we need to be looking for expertise elsewhere because we haven’t been pulling our weight.”

Edwin Asturias, a professor of paediatrics, infectious disease and epidemiology at the University of Colorado, called the loss of status a “stain” on the country’s public health programme. “Measles cases are a signal that your immunisation programme and other systems within your public health services are having problems,” he told Al Jazeera.

Asturias said the US had the resources and experience to prevent the virus’s resurgence, noting its success in eliminating local measles transmission for more than a quarter of a century. About 40 percent of current US cases are among adults older than 20, he said, underscoring the need to expand vaccination efforts. That could mean making vaccines available in workplaces, places of worship and other community settings, rather than relying solely on paediatricians and family doctors.

The loss of elimination status also has implications beyond US borders because measles can spread through international travel and migration. “The United States is not, anymore, a place where you’re safe from measles,” Asturias told Al Jazeera. “If you’re a common person walking around with your children, you need to know now that measles has come to the country to stay unless something else is done.” The risk is particularly concerning for unvaccinated people and those unable to receive the vaccine, including people with weakened immune systems or undergoing cancer treatment.

Public health experts say the PAHO announcement should prompt a more extensive vaccination response. They do not expect it to lead to a significant change in federal policy, but some hope it will spur action by state and local health departments.

Ferrari said the US could learn from countries with experience containing measles outbreaks, including India, where community health workers visit households to identify children who may have missed vaccinations or whose families may be reluctant to vaccinate. He also suggested states could reconsider vaccination strategies, including offering an earlier first or second dose to protect young children in areas where measles is circulating.

In the US, children routinely receive two MMR doses. The first is typically given at 12 to 15 months and the second at four to six years, before they start school. Two doses are about 97 percent effective at preventing measles. In countries with more widespread transmission, the second dose is often given between 18 and 24 months.

In June, Pennsylvania began recommending an additional early dose, called a “dose zero”, for infants aged six months and older in areas with sustained measles transmission. Ferrari said this is a perfect example of how states could adapt their approaches locally.

A broader shift in the federal response remains unlikely. CDC Director Erica Schwartz said last week the agency would continue “doing the same exact thing” in its measles response if the US lost its elimination status. Asturias said the federal response so far raises concerns about whether the country has the public health leadership needed to reverse the outbreak. “This is hard to see happen,” he said. “But at the same time it is predictable when you don’t have experts running a public healthcare system.”

The WHO credits measles with 95,000 deaths worldwide in 2024, mostly among children.